359 related articles for article (PubMed ID: 10630212)
1. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.
Emgård M; Karlsson J; Hansson O; Brundin P
Exp Neurol; 1999 Nov; 160(1):279-88. PubMed ID: 10630212
[TBL] [Abstract][Full Text] [Related]
2. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
3. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
4. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
5. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum.
Barker RA; Dunnett SB; Faissner A; Fawcett JW
Exp Neurol; 1996 Sep; 141(1):79-93. PubMed ID: 8797670
[TBL] [Abstract][Full Text] [Related]
6. Caspase inhibition increases embryonic striatal graft survival.
Mundt-Petersen U; Petersén A; Emgård M; Dunnett SB; Brundin P
Exp Neurol; 2000 Jul; 164(1):112-20. PubMed ID: 10877921
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in primary cultures of E14 rat ventral mesencephala: time course of dopaminergic cell death and implications for neural transplantation.
Branton RL; Clarke DJ
Exp Neurol; 1999 Nov; 160(1):88-98. PubMed ID: 10630193
[TBL] [Abstract][Full Text] [Related]
8. [Long-term survival of fetal substantia nigra grafts in striatum of PD rats: an observation of tyrosine hydroxylase immunohistochemistry and western blot].
Yang H; Cai W; Zhang K
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):13-5. PubMed ID: 10374499
[TBL] [Abstract][Full Text] [Related]
9. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
[TBL] [Abstract][Full Text] [Related]
10. Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains.
Robichon R; Jaafar A; Terqui M; Brachet P; Peschanski M
Exp Neurol; 2005 Aug; 194(2):333-40. PubMed ID: 16022861
[TBL] [Abstract][Full Text] [Related]
11. Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival.
Sortwell CE; Pitzer MR; Collier TJ
Exp Neurol; 2000 Oct; 165(2):268-77. PubMed ID: 10993687
[TBL] [Abstract][Full Text] [Related]
12. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
Heim RC; Willingham G; Freed WJ
Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
[TBL] [Abstract][Full Text] [Related]
13. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
14. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
15. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.
Duan WM; Rodrigues CM; Zhao LR; Steer CJ; Low WC
Cell Transplant; 2002; 11(3):195-205. PubMed ID: 12075985
[TBL] [Abstract][Full Text] [Related]
17. Programmed cell death in developing grafts of fetal substantia nigra.
Mahalik TJ; Hahn WE; Clayton GH; Owens GP
Exp Neurol; 1994 Sep; 129(1):27-36. PubMed ID: 7925840
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
Mendez I; Elisevich K; Flumerfelt B
J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
[TBL] [Abstract][Full Text] [Related]
19. An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Sortwell CE; Collier TJ; Camargo MD; Pitzer MR
Exp Neurol; 2004 May; 187(1):58-64. PubMed ID: 15081588
[TBL] [Abstract][Full Text] [Related]
20. Rat intrastriatal neural allografts challenged with skin allografts at different time points.
Duan WM; Cameron RM; Brundin P; Widner H
Exp Neurol; 1997 Nov; 148(1):334-47. PubMed ID: 9398476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
